Cardiac effects of vagus nerve stimulation in patients with major depression

Pharmacopsychiatry

Volumn 43, Issue 1, 2010, Pages 7-11

  Sperling, W ^a   Reulbach, U ^a,b   Bleich, S ^a   Padberg, F ^c   Kornhuber, J ^a   Mueck Weymann, M ^d  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; PAROXETINE; REBOXETINE; SERTRALINE; TRANYLCYPROMINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; FEMALE; HEART RATE; HEART RATE VARIABILITY; HOARSENESS; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; VAGUS NERVE STIMULATION;

EID: 76249094170     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1237374     Document Type: Article

References (24)

1. Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002 1 477-482
2. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001 104 2024-2028
3. Daban C, Martinez-Aran A, Cruz N, et al. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review. J Affect Disord 2008 110 1-15
4. Galli R, Limbruno U, Pizzanelli C, et al. Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation. Auton Neurosci 2003 107 52-59
5. George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005 58 364-373
6. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 2005 29 493-500
7. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002 59 S3-14
8. Kamphuis MH, Geerlings MI, Dekker JM, et al. Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. Eur J Cardiovasc Prev Rehabil 2007 14 796-802
9. Khaykin Y, Dorian P, Baker B, et al. Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can J Psychiatry 1998 43 183-186
10. Koenig SA, Longin E, Bell N, et al. Vagus nerve stimulation improves severely impaired heart rate variability in a patient with Lennox-Gastaut syndrome. Seizure 2008 17 469-472
11. Lederbogen F, Gernoth C, Weber B, et al. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. J Clin Psychopharmacol 2001 21 238-239
12. Mueck-Weymann M, Rechlin T, Ehrengut F, et al. Effects of olanzapine and clozapine upon pulse rate variability. Depress Anxiety 2002 16 93-99
13. Nemeroff CB, Mayberg HS, Krahl SE, et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006 31 1345-1355
14. Radespiel-Troger M, Rauh R, Mahlke C, et al. Agreement of two different methods for measurement of heart rate variability. Clin Auton Res 2003 13 99-102
15. Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol 1994 14 392-395
16. Ronkainen E, Korpelainen JT, Heikkinen E, et al. Cardiac autonomic control in patients with refractory epilepsy before and during vagus nerve stimulation treatment: a one-year follow-up study. Epilepsia 2006 47 556-562
17. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin psychiatry 2001 62 (Suppl 16) 10-17
18. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001 25 713-728
19. Schlaepfer TE, Frick C, Zobel A, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008 38 651-661
20. Siepmann M, Handel J, Mueck-Weymann M, et al. The effects of moclobemide on autonomic and cognitive functions in healthy volunteers. Pharmacopsychiatry 2004 37 81-87
21. Siepmann M, Werner K, Schindler C, et al. The effects of bupropion on heart rate variability in healthy volunteers. J Clin Psychopharmacol 2005 25 283-285
22. Sperling W, Reulbach U, Kornhuber J. Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry 2009 42 85-88
23. Stemper B, Devinsky O, Haendl T, et al. Effects of vagus nerve stimulation on cardiovascular regulation in patients with epilepsy. Acta Neurol Scand 2008 117 231-236
24. Zaaimi B, Grebe R, Berquin P, et al. Vagus nerve stimulation therapy induces changes in heart rate of children during sleep. Epilepsia 2007 48 923-930